Actively Recruiting
Effect of Upper Extremity Low-Volume High-Intensity Interval Training on Physical and Cognitive Functions in Heart Failure Patients
Led by Tarsus University · Updated on 2025-01-03
30
Participants Needed
2
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of upper extremity low-volume high-intensity interval training (LV-HIIT) on physical and cognitive functions in patients with heart failure with preserved ejection fraction (HFpEF). This randomized controlled trial includes clinically stable HFpEF patients who will be randomly assigned to either an intervention group or a control group. The study aims to assess changes in exercise capacity, muscle strength, cognitive function, and other health measures after 8 weeks of treatment. Participants in the LV-HIIT group will undergo training twice a week for 8 weeks using an arm ergometer. Each session includes 4 minutes of warm-up and cool-down at 50% maximum workload (Wmax), followed by 1 minute of intense training at 85-95% Wmax, and six intervals of 1-minute active recovery periods at 50-70% Wmax. The control group will continue with standard medical treatment without this specific exercise training. Throughout the study, participants will be assessed at the start and after 8 weeks for maximal arm exercise capacity, overall functional capacity, upper extremity muscle strength, reaction time, cognitive function, postural sway, and heart rate variability. Researchers will monitor these outcomes to understand the impact of the training program on physical and cognitive health in heart failure patients.
CONDITIONS
Official Title
Effects of Upper Extremity Low Volume HIIT in Heart Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical condition stable for 64 weeks.
- New York Heart Association functional classification I-II to III
- Over 18 years old
You will not qualify if you...
- History of CABG surgery
- Unstable angina pectoris
- Severe arrhythmia
- Acute pericarditis, endocarditis, myocarditis
- Severe left ventricular failure (EF <40%)
- Acute pulmonary embolism
- History of syncope
- Dissecting aneurysm
- Thrombophlebitis
- Orthopedic disorders that may interfere with exercise
- Uncontrolled hypertension, severe pulmonary arterial hypertension
- Moderate-severe valve disease
- Decompensated Congestive Heart Failure
- Electrolyte abnormalities
- Hypertrophic Cardiomyopathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Tarsus University, TARSUS, Mersin
Mersin, Mersin, Turkey (Türkiye)
Actively Recruiting
2
Nurel Ertürk, TARSUS, Mersin
Yenişehir, Mersin, Turkey (Türkiye)
Actively Recruiting
Research Team
N
Nurel ERTÜRK
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here